28.6 C
Friday, June 21, 2024

Nigeria recalls J&J children’s cough syrup due to fatal toxic substance

Nigeria recalls J&J children’s cough syrup due to fatal toxic substance

Nigeria’s health regulator on Wednesday said it has recalled a batch of Johnson & Johnson children’s cough syrup after finding an unacceptably high level of a potentially fatal toxic substance.

Laboratory tests on Benylin Paediatric showed a high level of diethylene glycol, which has been linked to the deaths of dozens of children in Gambia, Uzbekistan and Cameroon since 2022 in one of the world’s worst waves of poisoning from oral medication.

READ ALSO: WHO says COVID global health emergency is over

The syrup is used to treat cough and congestion-related symptoms, hay fever and other allergic reactions in children aged two to 12, Nigeria’s National Agency for Food and Drug Administration and Control (NAFDAC) said in a notice on its website.

“Laboratory analysis conducted on the product showed that it contains an unacceptable high level of Diethylene glycol and was found to cause acute oral toxicity in laboratory animals,” NAFDAC said.

Human consumption of the substance could cause symptoms like abdominal pain, vomiting, diarrhea, headaches and acute kidney injury that may result in death, the regulator added.

READ ALSO: Danjuma donates $1.36m to University of Ibadan College of Medicine

J&J referred a request for comment to Kenvue, which now owns the Benylin brand after a spin-off last year. Kenvue did not immediately respond to a request for comment, according to Reuters

The batch being recalled was made in South Africa in May 2021 with an expiration date of April 2024. The regulator urged those with bottles from the batch to discontinue use or sale and submit them to its nearest office.

Johnson & Johnson is a multinational pharmaceutical and medical technologies corporation that is at the forefront of healthcare innovation. The company’s focus on innovative medicine and MedTech solutions aims to address complex health challenges by developing cutting-edge treatments and technologies across various therapeutic areas.

Related Articles


Please enter your comment!
Please enter your name here

Stay Connected

- Advertisement -spot_img

Latest Articles